Surgical strategy for liver cancers in the era of effective chemotherapy.

@article{Shindoh2013SurgicalSF,
  title={Surgical strategy for liver cancers in the era of effective chemotherapy.},
  author={Junichi Shindoh and Ahmed Kaseb and J. Nicholas Vauthey},
  journal={Liver cancer},
  year={2013},
  volume={2 1},
  pages={47-54}
}
Systemic chemotherapy is the only option for advanced and/or disseminated disease in patients with hepatocellular carcinoma (HCC). For decades, various systemic therapies have been explored for the treatment of advanced HCC. Nevertheless, no satisfactory results have been obtained in cytotoxic chemotherapy so far. However, with the recent introduction of effective chemotherapy agents including sorafenib, the role of systemic therapy for the treatment of HCC is changing. The goals of systemic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Emerging role of Hpo signaling and YAP in hepatocellular carcinoma

Journal of hepatocellular carcinoma • 2015
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology • 2012

Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies

YL Cheah, P Chow
Liver Cancer • 2012

Similar Papers

Loading similar papers…